is semaglutide approved by fda Approves for New Indication Involving Cardiovascular Disease FDA approves obesity drug that

In the UK, NICE specifically recommends semaglutide (TA875) for adults with a BMI 35 kg/m (or 30 kg/m for certain ethnic groups) who have at least one weight-related comorbidity, with treatment limited to a maximum of 2 years

This could be helpful for someone who prefers not to have injections

It signals your pancreas to release insulin, which helps move sugar from your blood into your cells, where it can be used for energy

Perkovic V, Tuttle KR, Rossing P, et al

The consumption of sugary foods has been associated with elevated levels of triglycerides, which is another risk factor for cardiovascular disease [26, 27]

Current evidence indicates no clinically significant pharmacokinetic interactions with metformin, and no dose adjustments are needed [32]